Aptus is a full-service clinical CRO with industry-leading capabilities in designing and delivering early phase oncology & rare disease studies.
We understand the operational, logistical, and regulatory challenges associated with delivering such studies, and are the only clinical CRO that is part of the UK’s ATTC Network.
Aptus has the scale to deliver but small enough to be agile and provide a personal, custom service. We are passionate about partnering with our clients to get their great science and innovation to patients as quickly and safely as possible.
Our academic partnerships are supporting the use of patient wearables and AI to monitor/predict clinical outcomes.